Arcus Biosciences (RCUS) EBIT Margin (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Arcus Biosciences | 3.18 Bn | 2.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44,278.00 |
| Dec 31, 2025 | 20,070.00 |
| Sep 30, 2025 | -54,115.00 |
| Jun 30, 2025 | 43,071.00 |
| Mar 31, 2025 | -3,956.00 |
| Dec 31, 2024 | -17,740.00 |
| Sep 30, 2024 | 5,304.00 |
| Jun 30, 2024 | -26,076.00 |
| Mar 31, 2024 | 63,897.00 |
| Dec 31, 2023 | -40,000.00 |
| Sep 30, 2023 | 3,621.00 |
| Jun 30, 2023 | 5,779.00 |
| Mar 31, 2023 | -12,635.00 |
| Dec 31, 2022 | -553.00 |
| Sep 30, 2022 | 4,343.00 |
| Jun 30, 2022 | 11,667.00 |
| Mar 31, 2022 | -45,147.00 |
| Dec 31, 2021 | 90,512.00 |
| Sep 30, 2021 | -2,114.00 |
| Jun 30, 2021 | -3,582.00 |
| Mar 31, 2021 | -22,315.00 |
| Dec 31, 2020 | -54,817.00 |
| Sep 30, 2020 | 259,526.00 |
| Jun 30, 2020 | -97,000.00 |
| Mar 31, 2020 | -144,309.00 |
| Dec 31, 2019 | 114,875.00 |
| Sep 30, 2019 | 33,777.00 |
| Jun 30, 2019 | -59,354.00 |
| Mar 31, 2019 | -20,949.00 |
| Dec 31, 2018 | -58,022.00 |
| Sep 30, 2018 | 98,889.00 |
| Jun 30, 2018 | -20,544.00 |
| Mar 31, 2018 | 104.00 |
| Dec 31, 2017 | 1.31 Mn |